Terms: = Pancreatic cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA
132 results:
1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
2. Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study.
Gumpper-Fedus K; Chasser K; Pita-Grisanti V; Torok M; Pfau T; Mace TA; Cole RM; Belury MA; Culp S; Hart PA; Krishna SG; Lara LF; Ramsey ML; Fisher W; Fogel EL; Forsmark CE; Li L; Pandol S; Park WG; Serrano J; Van Den Eeden SK; Vege SS; Yadav D; Conwell DL; Cruz-Monserrate Z;
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00686. PubMed ID: 38284831
[TBL] [Abstract] [Full Text] [Related]
3. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract] [Full Text] [Related]
4. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract] [Full Text] [Related]
5. Novel Isotope-Labeled Derivatization Strategy for the Simultaneous Analysis of Fatty Acids and Fatty Alcohols and Its Application in Idiopathic Inflammatory Myopathies and pancreatic cancer.
Pu Q; Wang M; Jiang N; Luo Y; Li X; Hu C; Du D
Anal Chem; 2023 May; 95(21):8197-8205. PubMed ID: 37191225
[TBL] [Abstract] [Full Text] [Related]
6. Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Yuan M; Wu Q; Zhang M; Lai M; Chen W; Yang J; Jiang L; Cao J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):207-220. PubMed ID: 36915997
[TBL] [Abstract] [Full Text] [Related]
7. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
Xu K; Xia P; Chen X; Ma W; Yuan Y
Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
[TBL] [Abstract] [Full Text] [Related]
8. AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy.
Wu C; Dai C; Li X; Sun M; Chu H; Xuan Q; Yin Y; Fang C; Yang F; Jiang Z; Lv Q; He K; Qu Y; Zhao B; Cai K; Zhang S; Sun R; Xu G; Zhang L; Sun S; Liu Y
Theranostics; 2022; 12(18):7681-7698. PubMed ID: 36451864
[No Abstract] [Full Text] [Related]
9. Dynamic regulation of KIF15 phosphorylation and acetylation promotes focal adhesions disassembly in pancreatic cancer.
He Z; Wang J; Xu J; Jiang X; Liu X; Jiang J
Cell Death Dis; 2022 Oct; 13(10):896. PubMed ID: 36280663
[TBL] [Abstract] [Full Text] [Related]
10. Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with fanca mutation: A case report.
Lai YH; Tung KC; Chen SC
Medicine (Baltimore); 2022 Sep; 101(39):e30719. PubMed ID: 36181052
[TBL] [Abstract] [Full Text] [Related]
11. Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells.
Farhadi A; Homayouni Tabrizi M; Sadeghi S; Vala D; Khosravi T
J Biomater Sci Polym Ed; 2023 Feb; 34(3):315-333. PubMed ID: 36063019
[TBL] [Abstract] [Full Text] [Related]
12. Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.
Gong J; Thomassian S; Kim S; Gresham G; Moshayedi N; Ye JY; Yang JC; Jacobs JP; Lo S; Nissen N; Gaddam S; Tighiouart M; Osipov A; Hendifar A
Sci Rep; 2022 Sep; 12(1):15013. PubMed ID: 36056179
[TBL] [Abstract] [Full Text] [Related]
13. Focal adhesion proteins in hepatocellular carcinoma: RSU1 a novel tumour suppressor with prognostic significance.
Geramoutsou C; Nikou S; Karavias D; Arbi M; Tavlas P; Tzelepi V; Lygerou Z; Maroulis I; Bravou V
Pathol Res Pract; 2022 Jul; 235():153950. PubMed ID: 35642986
[TBL] [Abstract] [Full Text] [Related]
14. Bi-Functional Gold Nanorod-Protein Conjugates with Biomimetic BSA@Folic Acid Corona for Improved Tumor Targeting and Intracellular Delivery of Therapeutic Proteins in Colon cancer 3D Spheroids.
Jaiswal N; Halder S; Mahata N; Chanda N
ACS Appl Bio Mater; 2022 Apr; 5(4):1476-1488. PubMed ID: 35285613
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence of Germline Sequence Variations Among Patients With pancreatic cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced ROS-Boosted Phototherapy against pancreatic cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
17. Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC).
Gebauer F; Damanakis AI; Popp F; Quaas A; Kütting F; Lutz K; Held S; Deuß B; Göser T; Waldschmidt D; Bruns C
BMC Cancer; 2021 Nov; 21(1):1239. PubMed ID: 34794396
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score.
Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J
Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923
[TBL] [Abstract] [Full Text] [Related]
19. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
[TBL] [Abstract] [Full Text] [Related]
20. Systemic Therapy for Metastatic pancreatic cancer.
Ettrich TJ; Seufferlein T
Curr Treat Options Oncol; 2021 Oct; 22(11):106. PubMed ID: 34665339
[TBL] [Abstract] [Full Text] [Related]
[Next]
